Increased GFAP and insulin-like growth factor binding protein-2 (IGFBP-2) serum levels in GBM patients after radiotherapy have been shown to be correlated with the malignant degree and prognosis of GBM (wpr-669323). The gene discussed is IGFBP2; the disease is glioblastoma.